This message was sent to ##Email##
|
|
|
|
|
AST
CareDx, Inc., in collaboration with the AST Research Network, is seeking proposals for "Utility of Donor Derived Cell Free DNA."
The submission deadline has been extended to June 19, 2020, to support the needs of transplant professionals during the COVID-19 pandemic. The start of the grant term will remain October 1, 2020.
READ MORE
AST
The AST has published FAQ pages and other resources for both professionals and patients. Check out a full list of COVID-19 resources here.
AST
The AST's Infectious Disease Community of Practice has received queries from
transplant and donation colleagues regarding the novel coronavirus (2019-nCoV). These
FAQs were developed with input of members from both the organ donation
and transplantation communities to relay information on the current state of knowledge.
Check our website frequently, as these resources are being updated regularly.
READ MORE
|
Promoted by
|
|
|
|
 |
AST
Information regarding COVID-19 is changing rapidly. This document will be updated with the evolving issues related to medication access and drug shortages/supply chain issues within the United States of America during the pandemic.
AST
In the interest of facilitating patient care and advancing science, and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
Watch Video
|
|
AST
Congratulations to the 23 members who received the 2020 Fellow of the AST (FAST) designation at the 2020 AST Town Hall. These members have demonstrated an exceptional commitment to the field of transplantation as well as outstanding service to the AST.
Interested in applying for the FAST designation for 2021? Visit the FAST information page to learn more about the eligibility criteria. Applications will open this fall.
AST
To help us better understand the needs of our members, the AST has launched the Membership Value and Dues Survey. It's very important that we hear from YOU, our members, about whether we're meeting your needs, what we're doing well, and what we can do better. All participants in the survey will be eligible for a drawing to receive a $50 gift card.
Please check your email to access the survey.
 |
|
RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients.
Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula.
Learn more at relizorb.com REL20-310
|
|
AST
The Psychosocial and Ethical Community of Practice (PSECOP) invites you to participate in a brief research survey. Specifically, we are interested in transplant providers' psychosocial experiences with COVID-19, and resources for managing psychosocial responses to the current pandemic. Please consider participating by clicking the below link to begin this survey. Participation is voluntary and entirely anonymous.
READ MORE
Veloxis Pharmaceuticals
 Explore this phase 3 randomized, double-blind, double-dummy, multicenter, multinational, non-inferiority trial published in the American Journal of Transplantation. The study examined treatment failures defined as BPAR, graft failure, death, and delayed graft
function at 3 months and 12 months.
READ MORE
AST
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act would extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients, which is currently limited to just 36 months. Please take a moment to contact your Members of Congress about this important legislation. Contact Congress Today
|
|
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
AST
Mark Deierhoi, M.D., a stalwart in the rich history of transplantation of the University of Alabama at Birmingham and the state of Alabama, died Thursday, June 4, at his home in Birmingham. He was 68 years old.
READ MORE
|
|
Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely
Learn more
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
Liver Transplantation
We read the recently published article by Drs. Agopian, Verna and Goldberg with great interest. The authors have provided an important assessment of liver transplant volumes across the United Network for Organ Sharing (UNOS) regions from February to March of 2019 and 2020. The study revealed a significant center‐based difference in volume of transplant particularly among centers located in the same metropolitan areas including New York City.
READ MORE
American Journal of Transplantation
Ex‐vivo normothermic machine perfusion (NMP) of donor kidneys prior to transplantation provides a platform for direct delivery of cellular therapeutics to optimise organ quality prior to transplantation.
READ MORE
|
|
The Journal of Heart and Lung Transplantation
Early in the first thoracic transplant programs, renal
impairment resulting from treatment with calcineurin inhibitors such as cyclosporine or tacrolimus was recognized,
determining many patients' short- and long-term outcomes.
Most of the decline in renal function was irreversible, and
decreasing cyclosporine exposure reduced this decline. This
has since been confirmed in a randomized controlled trial in
thoracic transplantation recipients.
READ MORE
The Journal of Heart and Lung Transplantation
The contribution of lung transplantation to the treatment of patients with end-stage cystic
fibrosis (CF) has been debated. We aimed to describe achievable outcomes from high-volume CF and lung
transplant programs. This study reports on the largest single-center experience of lung transplantation for
adult and pediatric patients with CF. It also highlights the evolution of practice and outcomes over time.
READ MORE
The Journal of Heart and Lung Transplantation
The HeartMate 3 ventricular assist device (VAD) is a newer centrifugal continuous-flow VAD used for bridge-to-transplant and destination therapy in adults. However, there is
limited experience regarding its use in children and adults with complex congenital heart disease
(CHD).
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
